Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04809883 · ClinicalTrials.gov registry record
A Study to Evaluate Endoflip Normal Ranges Data in Healthy Volunteers
A clinical trial of Healthy, sponsored by Mayo Clinic.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT04809883: Completed study of Healthy, sponsored by Mayo Clinic.
NCT04809883 is a study of Healthy that has completed, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04809883, a study of Healthy, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to establish the normal range of diameter and distensibility of pylorus and the fasting and postprandial antro-pyloric motility in healthy adults.
Primary Outcome
Change in Pyloric diameter will be measured during fasting and postprandial using Endoflip
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Endoflip measurement of gastric and pyloric function
Study Locations (1)
Minnesota
- Michael Camilleri - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-03-06 |
| Est. Completion | 2021-06-23 |
What the finished NCT04809883 record still lists
NCT04809883 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Endoflip measurement of gastric and pyloric function is the first listed.
NCT04809883 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04809883 about?
NCT04809883 is a clinical study titled "A Study to Evaluate Endoflip Normal Ranges Data in Healthy Volunteers". The purpose of this research is to establish the normal range of diameter and distensibility of pylorus and the fasting and postprandial antro-pyloric motility in healthy adults.
What is the current status of trial NCT04809883?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2021-03-06. Estimated completion is 2021-06-23.
What conditions does trial NCT04809883 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT04809883?
The interventions under investigation include: Endoflip measurement of gastric and pyloric function (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04809883?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04809883 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04809883's enrollment target sits among peer trials
30 678th of 1090 higher than 363 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI